Tardive dyskinesia (TD) is an involuntary movement disorder associated with the use of neuroleptic medications. Although the disorder has become relatively common among psychiatric patients maintained on neuroleptics, there is currently no clear understanding of its pathophysiology and no effective treatment approach. Thus, the long-term objective of this application is to understand the etiology and natural history of TD. Such an understanding, we believe, will help to prevent and control this condition and its sequelae.
The specific aims of the proposed research are: (1) to identify demographic, neuropsychological, medical and psychosocial risk factors for TD among chronic neuroleptic users; (2) to describe the incidence of TD in two well-defined populations; (3) to identify prognostic factors for TD outcome; and (4) to assess current methods for defining and classifying cases of TD. Since June 1, 1985, we have been funded by NIMH to conduct interrelated studies of TD in a single source population, the outpatient division of the Connecticut Mental Health Center (CMHC), which is a state facility administered through a collaboration between Yale University and Connecticut's Department of Mental Health. Thus far, we have completed studies of TD prevalence (1), and the natural history of TD both on (2-4) and off (5,6) neuroleptic medication. In addition, a prospective study of TD incidence among 399 outpatients at risk was begun in 1985. To date, patient enrollment and biannual follow-up have proceeded according to schedule. In this competitive renewal, we are proposing to continue the incidence study of 262 subjects remaining at risk for five more years in order to increase the power for detecting TD risk factors. In addition, because there are findings suggesting differences in the rate of TD and its risk factors by severity of psychopathology and/or duration of treatment, we are proposing to apply the same design and methodology to 280 long-term hospitalized patients at Connecticut Valley Hospital (CVH) in Middletown, Connecticut, CVH treats psychotic patients who are too ill to be treated in the communities of CMHC's catchment area. Finally, we are proposing a prospective study of TD outcome among incident cases identified at CMHC and CVH in order to describe the course of disease and identify prognostic factors. Since this project focuses on the seriously mentally ill and involves a close collaboration between an academic site (CMHC) and a public-sector facility (CVH), it is submitted as a Public Academic Liaison (PAL) application.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
2R01MH039665-06
Application #
3377570
Study Section
Epidemiologic and Services Research Review Committee (EPS)
Project Start
1985-06-01
Project End
1993-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
6
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Schuldberg, D; Quinlan, D M; Glazer, W (1999) Positive and negative symptoms and and adjustment in severely mentally ill outpatients. Psychiatry Res 85:177-88
Morgenstern, H; Glazer, W M; Doucette, J T (1996) Handedness and the risk of tardive dyskinesia. Biol Psychiatry 40:35-42
Quinlan, D M; Schuldberg, D; Morgenstern, H et al. (1995) Positive and negative symptom course in chronic community-based patients. A two-year prospective study. Br J Psychiatry 166:634-41
Glazer, W M; Morgenstern, H; Doucette, J (1994) Race and tardive dyskinesia among outpatients at a CMHC. Hosp Community Psychiatry 45:38-42
Ziedonis, D M; Kosten, T R; Glazer, W M et al. (1994) Nicotine dependence and schizophrenia. Hosp Community Psychiatry 45:204-6
Morgenstern, H; Glazer, W M (1993) Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study. Arch Gen Psychiatry 50:723-33
Glazer, W M; Kane, J M (1992) Depot neuroleptic therapy: an underutilized treatment option. J Clin Psychiatry 53:426-33
Glazer, W M; Morgenstern, H; Niedzwiecki, D et al. (1988) Heterogeneity of tardive dyskinesia. A multivariate analysis. Br J Psychiatry 152:253-9
Morgenstern, H; Glazer, W M; Gibowski, L D et al. (1987) Predictors of tardive dyskinesia: results of a cross-sectional study in an outpatient population. J Chronic Dis 40:319-27